Table of Contents
|
|
|
1 |
A Brief History of Fetal Monitoring |
1 |
|
Historical Overview |
1 |
|
Randomized Trials of Electronic
Fetal Monitoring |
2 |
|
Fetal Heart Rate Monitoring
Research at the End of the Twentieth Century |
4 |
|
Fetal Assessment at the
Beginning of the Twenty-First Century |
4 |
2 |
Physiologic Basis for Monitoring |
9 |
|
Transfer of Oxygen from
Environment to Fetus |
9 |
|
External Environment |
10 |
|
Maternal Lungs |
10 |
|
Maternal Blood |
11 |
|
Maternal Heart |
12 |
|
Maternal Vasculature |
13 |
|
Uterus |
14 |
|
Placenta |
14 |
|
Fetal Blood |
19 |
|
Umbilical Cord |
20 |
|
Fetal Response to Disrupted
Oxygen Transfer |
22 |
|
Mechanisms of Injury |
22 |
|
Injury Threshold |
23 |
|
Summary |
25 |
3 |
Instrumentation for Fetal Heart Rate and Uterine
Activity Monitoring |
28 |
|
Auscultation of Fetal Heart Rate |
28 |
|
Description |
28 |
|
Leopold’s Maneuvers |
30 |
|
Frequency of Auscultation |
32 |
|
Documentation of Auscultated
Fetal Heart Rate |
33 |
|
interpretation of Auscultated
Fetal Heart Rate |
33 |
|
Benefits and Limitations of
Auscultation |
34 |
|
Electronic Fetal Monitoring |
35 |
|
Overview |
35 |
|
Converting Raw Data into a
Visual Display |
37 |
|
External Mode of Monitoring |
39 |
|
Ultrasound Transducer |
39 |
|
Tocotransducer |
42 |
|
Advantages and Limitations of
External Transducers |
45 |
|
Internal Mode of Monitoring |
45 |
|
Spiral Electrode |
45 |
|
Intrauterine Pressure Catheter |
49 |
|
Advantages and Limitations of
Internal Monitoring |
51 |
|
Display of Fetal Heart Rate,
Uterine Activity, and Other Information |
52 |
|
Monitor Tracing Scale |
54 |
|
Monitoring Twins and Multiples |
57 |
|
Artifact Detection |
58 |
|
Troubleshooting the Monitor |
58 |
|
Telemetry |
60 |
|
Central Displays |
62 |
|
Computer-Based Information
Systems |
63 |
|
Data-Input Devices |
67 |
|
ST Segment Analysis |
69 |
4 |
Evaluation of Uterine Activity |
73 |
|
Assessment Methods: Palpation
and Electronic Monitoring |
73 |
|
Palpation |
73 |
|
Electronic Monitoring |
74 |
|
Stages of |
77 |
|
Defining |
77 |
|
Defining Excessive Uterine
Activity |
79 |
|
Common Underlying Causes of
Excessive Uterine Activit |
85 |
|
Interventions to Decrease
Excessive Uterine Activity |
85 |
|
Diagnosis and Management of
Labor Abnormalities |
85 |
|
Latent Phase Abnormalities |
86 |
|
Active Phase Abnormalities |
87 |
|
Second Stage Abnormalities |
88 |
|
Uterine Activity and Oxytocin
Use |
88 |
|
Summary |
91 |
5 |
Pattern Recognition and Interpretation |
95 |
|
The Evolution of Standardized
Fetal Heart Rate Terminology |
95 |
|
Evidence-Based Interpretation of
Fetal Heart Rate Patterns |
96 |
|
National |
99 |
|
Five Basic Components of a Fetal
Heart Rate Tracing |
701 |
|
Terminology, Physiology, and
Interpretation of Specific Fetal Heart Rate Patterns |
101 |
|
Baseline Rate |
101 |
|
Definition |
101 |
|
Physiology |
103 |
|
Categories of Baseline Rate |
103 |
|
Tachycardia |
103 |
|
Definition |
103 |
|
Interpretation |
104 |
|
Bradycardia |
106 |
|
Definition |
106 |
|
Interpretation |
106 |
|
Baseline Fetal Heart Rate
Variability |
107 |
|
Definition |
107 |
|
Physiology |
108 |
|
Categories of Baseline
Variability |
109 |
|
Absent Variability |
109 |
|
Minimal Variability |
110 |
|
Moderate Variability |
112 |
|
Marked Variability |
113 |
|
Sinusoidal Pattern |
114 |
|
Accelerations |
114 |
|
Definition |
114 |
|
Physiology |
115 |
|
Interpretation |
115 |
|
Decelerations |
116 |
|
Definition |
116 |
|
Physiology |
116 |
|
Late Decelerations |
117 |
|
Definition |
117 |
|
Interpretation |
117 |
|
Early Decelerations |
119 |
|
Definition |
119 |
|
Interpretation |
120 |
|
Variable Decelerations |
121 |
|
Definition |
121 |
|
Interpretation |
121 |
|
Prolonged Decelerations |
123 |
|
Definition |
123 |
|
Interpretation |
124 |
|
Patterns Not Defined by the
National |
125 |
|
“Wandering Baseline” |
125 |
|
“Lambda” Pattern |
126 |
|
“Shoulder(s)” |
127 |
|
“Checkmark” Pattern |
128 |
|
“End-Stage” Bradycardia
and “Terminal” Bradycardia |
128 |
|
“Uniform” Accelerations |
129 |
|
“Atypical” Variable Decelerations |
129 |
|
“Good Variability within the
Deceleration” |
132 |
|
Summary |
134 |
6 |
Management of the Intrapartum
Fetal Heart Rate Tracing |
139 |
|
Management |
139 |
|
General Considerations |
139 |
|
Fundamental Principles |
140 |
|
Evaluate the Fetal Heart Rate
Tracing |
141 |
|
Evaluation of Five Essential
Fetal Heart Rate Components |
141 |
|
A - Assess the Oxygen Pathway |
142 |
|
B - Begin Corrective Measures |
142 |
|
Supplemental Oxygen |
143 |
|
Maternal Position Changes |
143 |
|
Intravenous Fluid Administration |
146 |
|
Correcting Maternal Blood
Pressure |
146 |
|
Reducing Uterine Activity |
147 |
|
Alter Second-Stage Pushing
Technique |
147 |
|
Amnioinfusion |
147 |
|
Re-evaiuate
Fetal Heart Rate After Corrective Measures |
14f |
|
C - Clear Obstacles to Rapid
Delivery |
148 |
|
D - Decision to Delivery Time |
149 |
|
Time Until Vaginal Delivery |
149 |
|
Time Until Possible Onset of
Metabolic Acidemia |
150 |
|
Responding to Acute Events |
150 |
|
Other Methods of Fetal Monitoring |
151 |
|
Intrapartum Fetal Scalp pH Determination |
151 |
|
Fetal Scalp Stimulation and Vibroacoustic
Stimulation |
151 |
|
Computer Analysis of Fetal Heart
Rate |
152 |
|
Fetal Pulse Oximetry |
152 |
|
ST Segment Analysis |
153 |
|
Umbilical Cord Acid-Base
Determination |
154 |
|
Approximate |
154 |
|
Types of Acidemia |
155 |
|
Summary |
156 |
7 |
Influence of Gestational Age on Fetal Heart Rate |
163 |
|
The Preterm Fetus |
163 |
|
Baseline Fetal Heart Rate in the
Preterm Fetus |
164 |
|
Periodic and Episodic Heart Rate
Changes in the Preterm Fetus |
164 |
|
Behavior States in the Preterm
Fetus |
165 |
|
Preterm Uterine Activity |
165 |
|
Tocolytic Agents and Effect on Fetal
Heart Rate |
168 |
|
Monitoring the Preterm Fetus |
169 |
|
The Postterm
Fetus |
170 |
|
Risks Associated with Postterm
Pregnancy |
171 |
|
Intrapartum Management |
172 |
|
Summary |
172 |
8 |
Fetal Assessment in Non-Obstetric Settings |
176 |
|
Emergency Services Department
Assessment and Care |
178 |
|
Pregnant Trauma Victim
Assessment and Care |
181 |
|
Maternal-Fetal Transport
Assessment and Care |
186 |
|
Non-Obstetric Surgery:
Maternal-Fetal Assessment and Care |
186 |
|
Surgery When Gestation is More
than 24 Weeks |
187 |
|
Federal Law and Triage |
188 |
|
Summary |
189 |
9 |
Antepartum Fetal Assessment |
191 |
|
Fundamental Determinations |
191 |
|
Contraction Stress Test and Oxytocin
Challenge Test |
193 |
|
Interpretation and Management |
193 |
|
Advantages and Limitations |
194 |
|
Procedures for Contraction
Stress Testing |
194 |
|
The Nonstress
Test |
196 |
|
Interpretation and Management |
197 |
|
Advantages and Disadvantages |
197 |
|
The Biophysical Profile |
198 |
|
Interpretation and Management |
T98 |
|
Advantages and Limitations |
199 |
|
The Modified Biophysical Profile |
200 |
|
Interpretation and Management |
200 |
|
Advantages and Limitations |
201 |
|
Fetal Movement Counts |
202 |
|
Interpretation and Management |
202 |
|
Umbilical Artery Doppler Velocimetry |
203 |
|
Biochemical Assessment |
203 |
|
Amniocentesis for Feta! Lung
Maturity |
203 |
|
Summary |
206 |
10 |
Patient Safety, Risk Management, and Documentation |
210 |
|
Occurrence of Errors |
210 |
|
Human Error |
211 |
|
Prevention of Errors and Risk
Reduction |
214 |
|
High-Reliability Perinatal
Units |
214 |
|
Creating a Circle of Safety™ |
215 |
|
Guidelines to Promote Safety and
Reduce Risks |
220 |
|
Management of Risks and Adverse
Outcomes |
224 |
|
Disclosure of Unanticipated
Outcomes |
225 |
|
Elements of Malpractice |
225 |
|
Notification and Clinical Review |
226 |
|
Reporting of Sentinel Events |
226 |
|
Failure Mode, Effect, and
Criticality Analysis |
227 |
|
Documentation |
227 |
|
Components of Care: Assessment,
Communication, Documentation |
229 |
|
Documentation Issues Specific to
Electronic Fetal Monitoring |
232 |
|
Electronic Medical Records and
Information Systems |
237 |
|
Summary |
241 |
Appendix A |
Amnioinfusion |
246 |
Appendix B |
Selected Pattern Interpretations at 1 cm/min
Paper Speed |
249 |
|
Glossary of Terms and Abbreviations |
266 |
|
|
|